PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
07-Jan-2020 How improving Complex Innovative Design trials could get innovative treatments to patients faster Complex Innovative Design (CID)
07-Jan-2020 Farxiga granted FDA Priority Review for patients with heart failure with reduced ejection fraction AstraZeneca
07-Jan-2020 Kyowa Kirin Announces Marketing Authorisation Application for Istradefylline Validated by European Medicines Agency Kyowa Kirin
07-Jan-2020 Novo Holdings REPAIR Impact Fund Invests USD 12 million in Mutabilis and IBT Vaccines and provides strategic update Novo Holdings
07-Jan-2020 Polyganics Achieves CE Mark Certification for LIQOSEAL® Polyganics
07-Jan-2020 Mobidiag Secures Additional Funding from Business Finland for Rapid Sepsis Diagnostic Test ESPOO
07-Jan-2020 Transgene and NEC Start Two Clinical Trials with TG4050, an individualized AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers Transgene
07-Jan-2020 Oxurion NV Reports Positive Topline Data from Phase 1 study evaluating THR-687 for treatment of DME Oxurion NV
07-Jan-2020 Yseop and Litera partner to fast-track regulation submission processes for Life Sciences companies Yseop
07-Jan-2020 Sebia enters into agreement with Sanofi to develop multiple myeloma diagnostic test Sebia
03-Jan-2020 Just two weeks to go until SMi’s flagship Pharmaceutical Microbiology UK Conference  SMi Group
24-Dec-2019 PharmaLink Announces Facility Expansion to Accommodate Growth PharmaLink
24-Dec-2019 Pharmaceutical Contract Manufacturing Market Fior Market Research LLP
24-Dec-2019 Venous Stents Market Fior Market Research LLP
23-Dec-2019 TEQ: Plastique brings cleanroom packaging manufacturing closer to home Plastique
23-Dec-2019 Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded Warrants Abeona Therapeutics
23-Dec-2019 Nanoform files for GMP certification Nanoform
23-Dec-2019 Abeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIA Abeona Therapeutics Inc
23-Dec-2019 AstraZeneca’s triple-combination therapy approved in China for patients with COPD AstraZeneca
23-Dec-2019 ViiV Healthcare receives complete response letter from US FDA for use of investigational cabotegravir and rilpivirine long-acting regimen in the treatment of HIV ViiV Healthcare